Patients of varied CV risk profiles achieve 24-hour BP control with highly tolerable and renoprotective calcium channel blocker

A prominent nephrologist discusses the effects of a calcium channel blocker (CCB) on blood pressure (BP) control in hypertensive patients with chronic kidney disease (CKD).